Merck KGaA (OTCMKTS:MKKGY) Sees Large Increase in Short Interest

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 16,700 shares, a growth of 4,075.0% from the December 15th total of 400 shares. Based on an average daily volume of 329,400 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group began coverage on shares of Merck KGaA in a report on Thursday, September 19th. They set a “buy” rating for the company.

Merck KGaA Stock Down 1.1 %

Shares of MKKGY stock traded down $0.33 during trading hours on Monday, hitting $29.22. 93,074 shares of the company’s stock traded hands, compared to its average volume of 152,879. The stock’s fifty day simple moving average is $29.93 and its two-hundred day simple moving average is $33.39. Merck KGaA has a 12-month low of $28.29 and a 12-month high of $39.17. The stock has a market cap of $18.88 billion, a price-to-earnings ratio of 18.04, a PEG ratio of 2.32 and a beta of 0.93. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.